Revolutionizing Cardiac Procedures: BioSig’s Pure EP System Showcases Time and Cost Efficiency at the 15th APHRS Scientific Session in Singapore
PURE EP™ Study Shows Promising Results at Asia-Pacific Heart Rhythm Society Conference Westport, CT, Dec. 14, 2022 BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, recently presented exciting findings at the premier…